TNX-102 SL, a sublingual cyclobenzaprine HCl formulation, is safe and effective for treating fibromyalgia symptoms, according to study results presented at the American College of Rheumatology (ACR) ...
(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) presented data at the ACR Convergence 2024 Annual Meeting showcasing the success of its Phase 3 RESILIENT study for TNX-102 SL, a ...
Tonix Pharmaceuticals (TNXP) presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, held November 14-19, 2024, in Washington, D.C. A copy of the Company’s presentation, ...